Abstract:We previously demonstrated that matrine could inhibit the proliferating, migrating, as well as invading processes of both PC-3 and DU145 cells. However, the underlying molecular mechanisms have not yet been clearly defined. In this study, using various techniques such as high throughput sequencing technology, bioinformatics, quantitative real-time PCR, and immunoblot analysis, we aimed to understand whether matrine serves as a novel regulator of FOXO and PI3K-AKT signaling pathway. DU145 and PC-3 cell lines were cultured for 24 h in vitro. Cells were treated with either matrine or control serum for 48 h, followed by extraction of total RNA. The RNA was sequenced using HiSeq 2500 high-throughput sequencing platform (Illumina). A gene library was established and quality analysis of read data carried out. Integrated database from the website DAVID was used to analyze Gene Ontology (GO), and Kyoto encyclopedia of genes and genomes (KEGG) pathway of differential genes was used for pathway analysis, screening for fold differences of more than two times. The FOXO and PI3K-AKT signaling pathways were screened, and expression levels of mRNA and core protein detected by real-time PCR and immunoblotting, respectively. High throughput sequencing and GO analysis revealed that differentially expressed genes before and after treatment played an important role in cell metabolic process, growth process, anatomical structure formation, cellular component organization, and biological regulation. KEGG signal pathway analysis revealed that FOXO and PI3K-AKT signal pathways had a significant difference between before and after matrine-treated androgen-independent prostate cancer cells PC-3 and DU145. Real-time PCR showed that matrine treatment led to a significant increase in the expression levels of FOXO1A, FOXO3A, FOXO4, and FOXO6 in DU145 and PC-3 cells (P<0.01 or P<0.05), whereas the PI3K expression levels decreased (P<0.01). Similarly, immunoblotting revealed a significant increase (P<0.05) in the expression levels of FOXO1A FOXO3A, FOXO4, and FOXO6 in both PC-3 and DU145 cells, whereas PI3K expression levels decreased (P<0.05). Matrine had a broad regulating effect on the mRNA expression profiles of both PC-3 and DU145 cells. Matrine may inhibit cell proliferation, migration, as well as invasion, and induce apoptosis in both PC-3 and DU145 cells through FOXO and PI3K-AKT signaling pathways. Matrine could therefore be used as a complementary drug to present chemotherapeutic agents, for treating androgen-independent prostate cancer.

Downregulation Of Mtor By Lentivirus Inhibits Prostate Cancer Cell Growth

Prostate-targeted Mtor-Shrna Inhibit Prostate Cancer Cell Growth in Human Tumor Xenografts.

Targeted Inhibition of Mtor by BML-275 Induces Mitochondrial-Mediated Apoptosis and Autophagy in Prostate Cancer.

Study on the Effect of mTOR on Androgen-independent Prostate Cancer

Activation of the Mammalian Target of Rapamycin Signalling Pathway in Prostate Cancer and Its Association with Patient Clinicopathological Characteristics

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention

Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer

Targeting Mtor for Cancer Therapy

The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling

MP84-06 CXCL8 COULD INDUCE AND MAINTAIN PROSTATE CANCER STEM CELLS VIA PI3K/AKT PATHWAY

Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma.

DEPTOR is an in Vivo Tumor Suppressor That Inhibits Prostate Tumorigenesis Via the Inactivation of Mtorc1/2 Signals

Regulatory Effects of Antitumor Agent Matrine on FOXO and PI3K-AKT Pathway in Castration-Resistant Prostate Cancer Cells

Tumor-suppressive Microrna-218 Inhibits Tumor Angiogenesis Via Targeting the Mtor Component RICTOR in Prostate Cancer.

MicroRNA181c Inhibits Prostate Cancer Cell Growth and Invasion by Targeting Multiple ERK Signaling Pathway Components

Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance

Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma.

Down-Regulation Of Signal Transducer And Activator Of Transcription 3 Expression Using Vector-Based Small Interfering Rnas Suppresses Growth Of Human Prostate Tumor In Vivo

miR-100-5p Downregulates mTOR to Suppress the Proliferation, Migration, and Invasion of Prostate Cancer Cells

Molecular Circuit Involving KLK4 Integrates Androgen and Mtor Signaling in Prostate Cancer

Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer